Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Med Chem ; 62(10): 4936-4948, 2019 05 23.
Article in English | MEDLINE | ID: mdl-31033293

ABSTRACT

An electronic density model was developed and used to identify a novel pyrrolotriazinone replacement for a quinazolinone, a commonly used moiety to impart selectivity in inhibitors for PI3Kγ and PI3Kδ. Guided by molecular docking, this new specificity piece was then linked to the hinge-binding region of the inhibitor using a novel cyclic moiety. Further structure-activity relationship optimization around the hinge region led to the discovery of candidate 26, a highly potent and selective PI3Kγ-PI3Kδ dual inhibitor with favorable drug metabolism and pharmacokinetic properties in preclinical species.


Subject(s)
Class I Phosphatidylinositol 3-Kinases/metabolism , Class Ib Phosphatidylinositol 3-Kinase/metabolism , Drug Discovery/methods , Phosphoinositide-3 Kinase Inhibitors/chemical synthesis , Animals , Arthritis, Experimental/drug therapy , Arthritis, Experimental/enzymology , Female , Humans , Isoenzymes , Mice , Molecular Docking Simulation , PC-3 Cells , Phosphoinositide-3 Kinase Inhibitors/chemistry , Phosphoinositide-3 Kinase Inhibitors/pharmacokinetics , Phosphoinositide-3 Kinase Inhibitors/pharmacology , RAW 264.7 Cells , Rats, Sprague-Dawley , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL